Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMC 2192727)

Published in J Exp Med on August 01, 1996

Authors

I Roth1, D B Corry, R M Locksley, J S Abrams, M J Litton, S J Fisher

Author Affiliations

1: Department of Anatomy, University of California San Francisco 94143, USA.

Articles citing this

Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86

Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords. Placenta (2008) 2.00

Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol (2000) 1.82

Immune reconstitution after unrelated cord blood transplantation. Cytotherapy (2007) 1.72

Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One (2008) 1.55

T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol (2005) 1.50

Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol (2004) 1.43

Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol (2004) 1.39

Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol (2007) 1.37

Listeriosis in the pregnant guinea pig: a model of vertical transmission. Infect Immun (2004) 1.35

CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A (2002) 1.30

Phenotypic characterization of human decidual macrophages. Clin Exp Immunol (2003) 1.24

The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm (2012) 1.22

The impact of differential antiviral immunity in children and adults. Nat Rev Immunol (2012) 1.21

Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol (2003) 1.21

The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol (2007) 1.20

Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol (2010) 1.17

Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol (2002) 1.17

Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J Exp Med (2001) 1.16

Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles. Am J Pathol (2001) 1.13

Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol (2001) 1.11

HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med (2009) 1.05

Cytomegalovirus in the neonate: immune correlates of infection and protection. Clin Dev Immunol (2013) 1.03

Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J Virol (2007) 1.02

Regulation of the Anti-Inflammatory Cytokines Interleukin-4 and Interleukin-10 during Pregnancy. Front Immunol (2014) 1.01

Chapter 12. Placental remodeling of the uterine vasculature. Methods Enzymol (2008) 1.01

Vascular IL-10: a protective role in preeclampsia. J Reprod Immunol (2011) 0.98

Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol (2011) 0.96

Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon. BMC Womens Health (2014) 0.94

Prevention of adult asthma by early intervention during childhood: potential value of new generation immunomodulatory drugs. Thorax (2000) 0.94

The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol (2013) 0.93

Role of IL-10 -819(t/c) promoter polymorphism in preeclampsia. Inflammation (2014) 0.92

Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. PLoS One (2012) 0.92

Programming for responsiveness to environmental antigens that trigger allergic respiratory disease in adulthood is initiated during the perinatal period. Environ Health Perspect (1998) 0.92

Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women. Clin Exp Immunol (2001) 0.92

Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol (2014) 0.91

B cells: the old new players in reproductive immunology. Front Immunol (2014) 0.87

Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma. Int J Biol Sci (2012) 0.87

Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med (2007) 0.86

Fetal-maternal alignment of regulatory T cells correlates with IL-10 and Bcl-2 upregulation in pregnancy. J Immunol (2013) 0.86

The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines. Immunology (2000) 0.86

Variations in cytokine mRNA expression during normal human pregnancy. Clin Exp Immunol (2000) 0.86

BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-gamma, interleukin-10 and transforming growth factor-beta1. Clin Exp Immunol (2008) 0.85

T-lymphocyte recovery and function after cord blood transplantation. Immunol Res (2011) 0.85

Evaluation of association of maternal IL-10 polymorphisms with risk of preeclampsia by A meta-analysis. J Cell Mol Med (2014) 0.84

Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr Immunol Rev (2010) 0.83

Maternal influence in the transmission of asthma susceptibility. Pulm Pharmacol Ther (2007) 0.83

Interleukin-10: a pleiotropic regulator in pregnancy. Am J Reprod Immunol (2014) 0.82

IL-10 modulates placental responses to TLR ligands. Am J Reprod Immunol (2009) 0.82

Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia. Clin Exp Immunol (2014) 0.81

Functionally mature virus-specific CD8(+) T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination? J Clin Invest (2003) 0.81

Cytokine dysregulation in early- and late-term placentas from feline immunodeficiency virus (FIV)-infected cats. Am J Reprod Immunol (2010) 0.81

IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy. Clin Exp Immunol (2002) 0.81

Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination. Clin Vaccine Immunol (2015) 0.80

The role of the invasive, placental trophoblast in human pregnancy. Wien Med Wochenschr (2012) 0.79

The immunobiology of cord blood transplantation. Korean J Hematol (2010) 0.78

Contraceptive vaccines targeting factors involved in establishment of pregnancy. Am J Reprod Immunol (2011) 0.78

Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage. J Clin Immunol (2000) 0.76

Comparison of the Functional microRNA Expression in Immune Cell Subsets of Neonates and Adults. Front Immunol (2016) 0.75

Preventive and therapeutic potential of placental extract in contact hypersensitivity. Int Immunopharmacol (2010) 0.75

In vitro progesterone modulation on bacterial endotoxin-induced production of IL-1β, TNFα, IL-6, IL-8, IL-10, MIP-1α, and MMP-9 in pre-labor human term placenta. Reprod Biol Endocrinol (2015) 0.75

Interleukin 10 (- 1082 G/A) and (- 819 C/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS). Meta Gene (2016) 0.75

Immunopathology of early pregnancy. Infect Dis Obstet Gynecol (1997) 0.75

Articles cited by this

Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 15.15

Interleukin-10. Annu Rev Immunol (1993) 10.14

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med (1991) 9.27

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today (1993) 8.00

Graft-versus-host disease. N Engl J Med (1991) 5.35

Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89

Implantation and the placenta: key pieces of the development puzzle. Science (1994) 4.75

IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol (1993) 4.65

Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med (1996) 4.54

A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 4.36

Biological properties of interleukin 10. Immunol Today (1992) 3.62

Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev (1992) 3.42

92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol (1991) 2.79

An autonomous signal for basolateral sorting in the cytoplasmic domain of the polymeric immunoglobulin receptor. Cell (1991) 2.71

Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol (1993) 2.65

Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Methods (1993) 2.62

Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol (1995) 2.54

Distribution of beta2 microglobulin and HLA in chorionic villi of human placentae. Nature (1976) 2.30

The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res (1968) 2.26

Integrin switching regulates normal trophoblast invasion. Development (1994) 2.23

Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol (1989) 2.12

Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol (1992) 2.04

T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA (1995) 2.03

Isolation of hormone-producing clonal lines of human choriocarcinoma. J Clin Endocrinol Metab (1971) 1.89

Expression and analysis of the polymeric immunoglobulin receptor in Madin-Darby canine kidney cells using retroviral vectors. Methods Cell Biol (1989) 1.75

Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev (1992) 1.64

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood (1995) 1.52

Distribution of MHC antigens in human placental chorionic villi. Transplant Proc (1977) 1.50

Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology (1986) 1.43

Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology (1988) 1.41

High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun (1995) 1.36

Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem (1994) 1.36

Immunobiology of the maternal-fetal relationship. Annu Rev Med (1979) 1.32

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer (1993) 1.31

Extracellular matrix 5: adhesive interactions in early mammalian embryogenesis, implantation, and placentation. FASEB J (1993) 1.18

Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol (1992) 1.18

Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol (1994) 1.16

Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol (1990) 1.15

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med (1993) 1.10

Immunologic and endocrine interrelationships in pregnancy. Biol Reprod (1982) 1.08

Biosynthesis of human placental proteins and human placental lactogen (HPL) in vitro. II. Dynamic studies of normal term placentas. Endocrinology (1969) 1.03

Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs. J Exp Med (1993) 1.00

Placenta as an immunological barrier. Biol Reprod (1982) 0.98

Production of interleukin-6 by normal human trophoblast. Placenta (1990) 0.94

Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol (1995) 0.91

Trophoblast-derived interleukin-6 (IL-6) regulates human chorionic gonadotropin release through IL-6 receptor on human trophoblasts. J Clin Endocrinol Metab (1990) 0.91

Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol (1994) 0.88

Trophoblasts protect the inner cell mass from macrophage destruction. Biol Reprod (1993) 0.87

Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab (1991) 0.83

C-jun and jun-B oncogene expression during placental development. Am J Obstet Gynecol (1991) 0.82

Localization and production of human macrophage colony-stimulating factor (hM-CSF) in human placental and decidual tissues. Lymphokine Cytokine Res (1993) 0.78

Soluble factors produced by isolated first-trimester chorionic villi directly inhibit proliferation of T cells. Am J Obstet Gynecol (1990) 0.78

Immunoregulatory activity in supernatants from cultures of normal human trophoblast cells of the first trimester. Am J Obstet Gynecol (1989) 0.78

Are there immunologically mediated abortions? If so, which mechanisms? Res Immunol (1990) 0.77

Articles by these authors

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med (1989) 11.36

Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76

Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science (2000) 10.14

The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 8.05

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med (1990) 6.35

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12

The instructive role of innate immunity in the acquired immune response. Science (1996) 5.50

Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity (2001) 5.46

Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U S A (1991) 4.95

Implantation and the placenta: key pieces of the development puzzle. Science (1994) 4.75

Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature (1992) 4.57

Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med (1996) 4.54

A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 4.36

Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest (1997) 3.93

Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity (2001) 3.84

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest (1997) 3.76

Retracted Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol (1990) 3.76

Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51

Regulation of human placental development by oxygen tension. Science (1997) 3.49

The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet (2000) 3.49

Implantation and the survival of early pregnancy. N Engl J Med (2001) 3.19

Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04

Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03

Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med (1994) 3.02

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med (1994) 2.88

Expression cloning of a protective Leishmania antigen. Science (1995) 2.83

92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol (1991) 2.79

IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67

Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat Immunol (2001) 2.62

Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Methods (1993) 2.62

Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med (1998) 2.59

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity (1997) 2.54

Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol (1995) 2.54

Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest (1992) 2.38

Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J Immunol (1986) 2.38

Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest (1996) 2.29

Integrin switching regulates normal trophoblast invasion. Development (1994) 2.23

Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science (1998) 2.13

High-dose chemotherapy for breast cancer. Ann Intern Med (1996) 2.09

Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity (1999) 2.09

Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest (1993) 2.07

Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol (2009) 2.01

Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00

Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00

Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J Immunol (1991) 1.89

Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem (2000) 1.89

TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science (1993) 1.89

Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. J Immunol (1987) 1.86

Altered immune responses in interleukin 10 transgenic mice. J Exp Med (1997) 1.85

Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med (1997) 1.83

Gamma delta T lymphocytes in human tuberculosis. J Infect Dis (1992) 1.78

Infection with varicella-zoster virus after marrow transplantation. J Infect Dis (1985) 1.77

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77

The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74

Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72

Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71

Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol (1995) 1.69

Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J Exp Med (1996) 1.68

Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr Opin Cell Biol (1998) 1.68

Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol (1999) 1.65

Airway inflammation and remodeling in asthma. Curr Opin Pulm Med (2000) 1.64

Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytes. Science (2001) 1.64

Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J Clin Invest (1982) 1.64

Susceptibility of Legionella pneumophila to oxygen-dependent microbicidal systems. J Immunol (1982) 1.61

Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science (1986) 1.60

Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60

Increasing incidence of right-sided lesions in colorectal cancer. Am J Surg (1979) 1.58

Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J Immunol (1999) 1.58

High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51

Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med (2000) 1.51

Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol (2000) 1.48

A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med (2001) 1.48

Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest (1993) 1.47

Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol (1997) 1.47

Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci U S A (1994) 1.47

The exposure of health care workers to ribavirin aerosol. JAMA (1989) 1.46

A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. J Clin Oncol (1989) 1.46

Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod (2006) 1.45

Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells. J Immunol (2000) 1.45

Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun (1993) 1.44

Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J Exp Med (1998) 1.44

Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J Immunol (1994) 1.43

Bone marrow cell trafficking following intravenous administration. Br J Haematol (1999) 1.43

Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol Med (1995) 1.43

Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42

Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med (1995) 1.42

Structure and heterogeneity of the oligosaccharides from the lipopolysaccharides of a pyocin-resistant Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1989) 1.41

IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39

APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol (1999) 1.38

IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol (1997) 1.38